Emily R. Ko

Baricitinib plus Remdesivir for Hospitalized Adults with Covid-19

André C. Kalil, Thomas F. Patterson, Aneesh K. Mehta et al. · New England Journal of Medicine · 2020 · 1.9K citations · Full text

Medicine, Clinical Sciences, Pharmacotherapy +14

Host gene expression classifiers diagnose acute respiratory illness etiology

Ephraim L. Tsalik, Ricardo Henao, Marshall Nichols et al. · Science Translational Medicine · 2016 · 269 citations · Full text

Life Sciences, Infectious Diseases, Microbiology +16

Baricitinib versus dexamethasone for adults hospitalised with COVID-19 (ACTT-4): a randomised, double-blind, double placebo-controlled trial

Cameron R. Wolfe, Kay M Tomashek, Thomas F. Patterson et al. · The Lancet Respiratory Medicine · 2022 · 128 citations · Full text

Medicine, Internal Medicine, Pharmacotherapy +3

An atlas connecting shared genetic architecture of human diseases and molecular phenotypes provides insight into COVID-19 susceptibility

Liuyang Wang, Thomas J. Balmat, Alejandro L. Antonia et al. · Genome Medicine · 2021 · 73 citations · Full text

Life Sciences, Genetics, Molecular Genetics +15

Abatacept, Cenicriviroc, or Infliximab for Treatment of Adults Hospitalized With COVID-19 Pneumonia

Jane A. O’Halloran, Emily R. Ko, Kevin J. Anstrom et al. · JAMA · 2023 · 67 citations · Full text

Pharmacy, Immunology, Pharmacotherapy +11